Woo Kyung Lee Doolittle

12PUBLICATIONS
17CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 17, 2024
Correction: Regulation of cancer stem cell activity by thyroid hormone receptor β.

Woo Kyung Lee Doolittle, Xuguang Zhu, Sunmi Park

|Apr 26, 2024
Macrophage-Induced Carboxypeptidase A4 Promotes the Progression of Anaplastic Thyroid Cancer.

Yeon-Sook Choi, Min Ji Jeon, Woo Kyung Lee Doolittle

|Dec 20, 2023
Inhibition of MEK Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer.

Takahito Kimura, Woo Kyung Lee Doolittle, Michael Kruhlak

|Aug 26, 2023
Thyroid hormone receptor α1: a novel regulator of thyroid cancer cell differentiation.

Eunmi Hwang, Woo Kyung Lee Doolittle, Yuelin Jack Zhu

|Mar 20, 2023
Reactivated thyroid hormone receptor β attenuates anaplastic thyroid cancer (ATC) stem cell activity.

Xuguang Zhu, Li Zhao, Woo Kyung Lee Doolittle

Pageof 2